Prognosis prediction model based on competing endogenous RNAs for recurrence of colon adenocarcinoma

Li Peng Jin,Tao Liu,Fan Qi Meng,Jian Dong Tai
DOI: https://doi.org/10.1186/s12885-020-07163-y
IF: 4.638
2020-10-07
BMC Cancer
Abstract:Abstract Background Colon adenocarcinoma (COAD) patients who develop recurrence have poor prognosis. Our study aimed to establish effective prognosis prediction model based on competing endogenous RNAs (ceRNAs) for recurrence of COAD. Methods COAD expression profilings downloaded from The Cancer Genome Atlas (TCGA) were used as training dataset, and expression profilings of GSE29623 retrieved from Gene Expression Omnibus (GEO) were set as validation dataset. Differentially expressed RNAs (DERs) between non-recurrent and recurrent specimens in training dataset were screened, and optimum prognostic signature DERs were revealed to establish prognostic score (PS) model. Kaplan-Meier survival analysis was conducted for PS model, and GEO dataset was used for validation. Prognosis prediction efficiencies were evaluated by area under curve (AUC) and C-index. Meanwhile, ceRNA regulatory network was constructed by using signature mRNAs, lncRNAs and miRNAs. Results We identified 562 DERs including 42 lncRNAs, 36 miRNAs, and 484 mRNAs. PS prediction model, consisting of 17 optimum prognostic signature DERs, showed that high risk group had significantly poorer prognosis (5-year AUC = 0.951, C-index = 0.788), which also validated in GSE29623. Prognosis prediction model incorporating multi-RNAs with pathologic distant metastasis (M) and pathologic primary tumor (T) (5-year AUC = 0.969, C-index = 0.812) had better efficiency than clinical prognosis prediction model (5-year AUC = 0.712, C-index = 0.680). In the constructed ceRNA regulatory network, lncRNA NCBP2-AS1 could interact with hsa-miR-34c and hsa-miR-363 , and lncRNA LINC00115 could interact with hsa-miR-363 and hsa-miR-4709 . SIX4 , GRAP , NKAIN4 , MMAA , and ERVMER34–1 are regulated by hsa-miR-4709 . Conclusion Prognosis prediction model incorporating multi-RNAs with pathologic M and pathologic T may have great value in COAD prognosis prediction.
oncology
What problem does this paper attempt to address?
### The Problem This Paper Attempts to Solve This paper aims to address the issue of prognosis prediction for patients with recurrent colon adenocarcinoma (COAD). Specifically: 1. **Background**: - Patients with colon adenocarcinoma who experience recurrence generally have a poor prognosis. - The research aims to establish a recurrence prognosis prediction model based on competing endogenous RNAs (ceRNAs). 2. **Research Methods**: - Data from The Cancer Genome Atlas (TCGA) was used as the training set, including 367 samples (279 non-recurrent, 88 recurrent). - GSE29623 data from the Gene Expression Omnibus (GEO) was used as the validation set, including 65 samples. - Differentially expressed RNAs (DERs) were screened, and the optimal prognostic markers were determined using lasso regression with an L1 penalty to construct a prognostic score (PS) model. - The PS model was evaluated using Kaplan-Meier survival analysis and validated with GEO data. 3. **Results**: - 562 DERs were identified, including 42 long non-coding RNAs (lncRNAs), 36 microRNAs (miRNAs), and 484 messenger RNAs (mRNAs). - A PS prediction model containing 17 optimal prognostic markers was established, with significantly poorer prognosis in the high-risk group (5-year AUC = 0.951, C-index = 0.788). - A multi-RNA prognostic model combining pathological distant metastasis (M) and primary tumor (T) information (5-year AUC = 0.969, C-index = 0.812) performed better than the clinical prognosis model alone (5-year AUC = 0.712, C-index = 0.680). - A ceRNA regulatory network was constructed, revealing that lncRNA NCBP2-AS1 can interact with hsa-miR-34c and hsa-miR-363, while lncRNA LINC00115 can interact with hsa-miR-363 and hsa-miR-4709. 4. **Conclusion**: - The prognostic prediction model combining multi-RNA with pathological M and pathological T has high value in COAD prognosis prediction. - lncRNA LINC00115 may regulate the expression of SIX4, GRAP, NKAIN4, MMAA, and ERVMER34-1 by acting as a ceRNA interacting with hsa-miR-4709, which is highly associated with COAD recurrence.